The board said in a press statement that manufacturing units of curry powders and garam masalas should make sure the imported consignments of these spices are free from Chrysoidine, so as to avoid rejection and recall of exports.
The board issued the press release after a rapid alert notification by the European Union (EU). The notification issued by the European Commission (Health & Consumers, Directorate General) in Brussels observed that Chrysoidine is a genotoxic carcinogen, exposure to which in a person's diet would increase the risk of cancer. It also informed that there are no analytical methods available now to test this.
The EU notification, which stated they had received this information through their normal horizon scanning activities, maintained it was in relation to the consignment destined for the Indian market.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app